Visual function improvement in patients with macroprolactinomas treated with bromocriptine

R. L. Lesser, J. D. Zheutlin, D. Boghen, J. G. Odel, Richard J. Robbins

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

We studied eight patients who had visual field defects secondary to prolactin-secreting macroadenomas and who had improved visual function with bromocriptine treatment without surgery or radiation. We recommend bromocriptine as a primary treatment for prolactin-secreting macroadenomas. If therapy is effective, continued regular neuro-ophthalmologic, endocrine, and imaging studies are necessary, because treatment with bromocriptine must be continued indefinitely.

Original languageEnglish (US)
Pages (from-to)535-543
Number of pages9
JournalAmerican Journal of Ophthalmology
Volume109
Issue number5
DOIs
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Visual function improvement in patients with macroprolactinomas treated with bromocriptine'. Together they form a unique fingerprint.

Cite this